Welcome to our dedicated page for PRF Technologies Ltd. SEC filings (Ticker: PRFX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
PRF Technologies Ltd. filings document a foreign private issuer with healthcare and solar analytics operations. Current reports on Form 6-K disclose regulatory and development updates for OcuRing™-K, LayerBio’s sustained-release ocular drug-delivery platform, as well as DeepSolar commercial agreements, SaaS deployments, technical due diligence services, patent-related activity, and business updates tied to the company’s operating platforms.
The filing record also covers capital structure and governance matters, including ordinary-share financing arrangements, registration statement incorporation for Form F-3 and Form S-8 purposes, board and executive changes, committee independence, and share-capital actions. PRF’s annual reporting on Form 20-F provides the broader framework for its business, risk factors, operating results, subsidiaries, and public-company controls.
PRF Technologies Ltd. interim CEO Cohen-Arazi Efraim filed an initial ownership report listing direct holdings of several employee stock option grants over the company’s Ordinary Shares. These options give the right to buy shares at exercise prices ranging from 15.7500 to 5400.0000 per share, with expirations between 2031 and 2035.
Footnotes explain that the options were granted under the 2019 PainReform Option Plan and, to qualify for Israeli tax benefits under Section 102, must be registered in the name of a trustee. They also outline vesting schedules, with some grants already fully vested and others vesting in quarterly installments through 2028, contingent on continued service.
PRF Technologies Ltd. executive chairman Ehud Geller filed an initial Form 3 showing his derivative holdings in employee stock options over ordinary shares. The filing lists several option grants under the 2019 PainReform Option Plan, fully vested on their respective grant dates, with exercise prices ranging from 0.0500 to 5400.0000 and expirations between 2031 and 2035. These entries reflect existing option positions rather than new purchases or sales.
PRF Technologies Ltd. filed an initial ownership report for Chief Financial Officer Broder Eyal, showing existing stock option awards rather than new share purchases or sales. He holds options over 180 ordinary shares at an exercise price of $30.0000 expiring on October 10, 2034, fully vested on the grant date. He also holds options over 2,000 ordinary shares at an exercise price of $15.7500 expiring on February 20, 2035, with 500 options vested at appointment and the remaining 1,500 vesting in equal quarterly installments beginning on May 20, 2026, subject to his continued service.
PRF Technologies Ltd. director Augustine Lawlor reported his initial holdings of stock options linked to the company’s ordinary shares. These are compensation awards rather than open-market trades.
One option covers 50 ordinary shares at an exercise price of 5,400 per share, expiring on February 23, 2031, and is fully vested from a February 23, 2021 grant under the 2019 PainReform Option Plan. A second option covers 183 ordinary shares at an exercise price of 30 per share, expiring on July 18, 2034. Of this grant, 160 options were vested on the appointment date, and the remaining 23 are scheduled to vest in two quarterly installments on April 18, 2026 and July 18, 2026, contingent on continued service.
PRF Technologies Ltd. director Shavit Asaf reported holding employee stock options linked to 3,000 Ordinary Shares. These options have an exercise price of 5.55 per share and expire on November 24, 2035.
The options were granted under the 2019 PainReform Option Plan and will vest in equal quarterly installments starting three months after the November 24, 2025 grant date, becoming fully vested three years after that date if his service continues. For Israeli tax benefits under Section 102 of the Israeli Tax Ordinance, the securities must be registered in the name of a trustee.
PRF Technologies Ltd. reported a new commercial collaboration agreement with Blade Ranger Ltd. to help expand deployments of its DeepSolar AI-driven solar analytics platform across utility-scale solar portfolios, targeting engagements of at least 150 megawatts each.
Under the agreement, Blade Ranger will identify and introduce potential large solar customers. As consideration, Blade Ranger may receive warrants to purchase 100,000 restricted ordinary shares for each of up to three prospects that sign binding DeepSolar agreements meeting the minimum 150 megawatt scope, for a maximum of 300,000 shares. The warrants carry a $0.01 exercise price per share and a 12‑month term from issuance.
PRF has also agreed, upon Blade Ranger’s written request, to register the warrant shares for resale, with Blade Ranger reimbursing half of the related registration costs. The filing highlights PRF’s strategy to grow DeepSolar alongside its pharmaceutical programs by partnering with a specialist in large‑scale renewable energy infrastructure.
PRF Technologies Ltd. reported several leadership changes. The board appointed Efi Cohen-Arazi as interim CEO, effective immediately, replacing Ehud Geller, who will remain Executive Chairman. Cohen-Arazi stepped down from the Audit and Compensation Committees, and director Asaf Shavit was appointed to both committees.
The company also confirmed Eyal Broder, previously interim CFO since October 2024, as permanent CFO with no changes to his existing compensation terms. The board stated that the committee resignations and CEO transition were not due to any disagreement with the company or its management. The filing also highlights the extensive industry and financial experience of Cohen-Arazi, Broder and Shavit.
PRF Technologies Ltd. reported that its DeepSolar business unit has signed a solar analytics services agreement with a subsidiary of EDF Group, a global renewable-energy leader. The engagement covers technical due diligence for an operational, utility-scale solar power plant in Israel.
This is DeepSolar’s first commercial due diligence engagement and follows the launch of its Smart TDD service, which analyzes historical and operational plant data. The Smart TDD platform is designed to provide structured, independent technical reviews that help solar asset owners assess condition, performance, and asset-level decision-making.
PRF Technologies Ltd. furnished a report describing a new commercial software-as-a-service agreement for its DeepSolar AI-driven solar analytics platform with Shikun & Binui Energy for the 71 megawatt Satu Mare utility-scale solar plant in Romania. This is positioned as an ongoing commercial deployment rather than a pilot.
DeepSolar will provide continuous analytics and performance monitoring to improve operational visibility, anomaly detection, and data-driven asset management for the plant. PRF highlights this win as part of a broader European expansion, alongside prior DeepSolar pilots and new products such as Smart TDD for technical due diligence and DeepSolar Predict for forecasting, supported by a patent filing in plant-level micro-climate modeling.
PRF Technologies Ltd. is implementing a 1-for-5 reverse share split of its ordinary shares, consolidating every five existing shares into one new share with no par value. The company’s ordinary shares are expected to begin trading on the Nasdaq Capital Market on this adjusted basis on February 6, 2026.
After the reverse split, authorized share capital will consist of 12,000,000 ordinary shares, and issued and outstanding shares will change from 3,915,340 to 783,068, with fractional shares rounded up to the nearest whole share. Exercise prices and share amounts under all outstanding options and warrants will be adjusted proportionately so holders retain equivalent economic value on a post-split basis.